Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion. Wilks A, Steinberg MH, Frangoul H. Blood 2025;146:2385-2391.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilks A, Steinberg MH, Frangoul H. Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion. Blood 2025;146:2385-2391.
PMID: 40834880